Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings

Circulation

Volumn 105, Issue 5, 2002, Pages 595-601

  Lubien, Emily ^a   DeMaria, Anthony ^a   Krishnaswamy, Padma ^a   Clopton, Paul ^a   Koon, Jen ^a   Kazanegra, Radmila ^a   Gardetto, Nancy ^a   Wanner, Erin ^a   Maisel, Alan S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diastole; Echocardiography; Peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASE; COLOR ULTRASOUND FLOWMETRY; CONGESTIVE HEART FAILURE; DIAGNOSTIC VALUE; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ENZYME IMMUNOASSAY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HUMAN; INTERMETHOD COMPARISON; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; AREA UNDER CURVE; ATRIAL FUNCTION, LEFT; ATRIAL NATRIURETIC FACTOR; CHRONIC DISEASE; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; ODDS RATIO; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0037022231     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc0502.103010     Document Type: Article

References (36)

1. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective
2. Left ventricular diastolic dysfunction as a cause of congestive heart failure
3. Left ventricular diastolic dysfunction in patients with congestive heart failure
4. Pitfalls in the echo-Doppler assessment of diastolic dysfunction
5. Prospects for using a blood sample in the diagnosis of heart failure
6. Natriuretic peptides: Relevance in cardiac disease
7. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
8. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immu-noradiometric assays in normal subjects and in patients with different degrees of heart failure
9. Utility of B-type natriuretic peptide (BNP) in the diagnosis of CHF in an urgent care setting
10. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin
11. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
12. Biochemical detection of left-ventricular systolic dysfunction
13. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
14. Superiority of brain natriuretic peptide is related to diastolic dysfunction in hypertension
15. Diastolic dysfunction and natriuretic peptides in systolic heart failure
16. Left ventricular volume from paired biplane two-dimensional echocardiography
17. Left ventricular function in geriatric patients
18. Diastolic dysfunction in elderly patients with congestive heart failure
19. The natural history of left ventricular filling abnormalities: Assessment of two-dimensional and Doppler echocardiography
20. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling
21. Relation of transmitral flow velocity patterns to left ventricular function: New insights from a combined he-modynamic and Doppler echocardiographic study
22. Doppler assessment of diastolic function comes of age
23. Evaluation of diastolic filling of the left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone
24. Rapid transcriptional activation and early m RNA turnover of BNP in cardiocyte hypertrophy: Evidence for BNP as an "emergency" cardiac hormone against ventricular overload
25. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with CHF
26. Plasma brain natriuretic peptide is a marker for the prediction of progressive ventricular remodeling after acute myocardial infarction
27. A rapid bedside test for brain natriuretic peptide accurately predicts cardiac function in patients referred for echo-cardiography
28. Predictive properties of serum prostate-specific antigen testing in a community-based setting
29. Enhancing and evaluating diagnostic accuracy
30. Meta-analysis of Pap test accuracy
31. Estimation of left-ventricular diastolic pressures from precordial pulsed-Doppler analysis of pulmonary venous and mitral flow
32. Clinical criteria and biochemical markers for the detection of systolic dysfunction
33. Defining diastolic heart failure: A call for standardized diagnostic criteria
34. A rapid bedside test for b-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure
35. A rapid test for b-type natriuretic peptide (BNP) correlates with falling wedge pressures in patients treated for decompensated heart failure: A pilot study